Vertex Pharmaceuticals Inc. closed $45.72 below its 52-week high ($510.64), which the company achieved on August 1st.

Robert W. Baird has recently initiated Vertex Inc (VERX) stock to Outperform rating, as announced on July 23, 2024, according to Finviz. Earlier, on March 1, 2024, BofA Securities had raised the stock ...

Vertex, Inc. (NASDAQ: VERX) has launched Vertex for Salesforce Revenue Cloud, an integration designed to streamline revenue ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

Vertex, Inc. (NASDAQ: VERX) has been honored with the 2024 Oracle Partner Awards in the Best in Class and North American ...

A survey asked over 600 participants about their use of virtual backgrounds, including static images, blurred images, videos, ...

This was the stock's second consecutive day of losses.

Lockheed Martin ( NYSE: LMT) and Rolls Royce (LON: RR) Allen views this as one of the megatrends of the next five years, with ...